Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CMMB

Chemomab Therapeutics Ltd.

CIK 0001534248 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.83
↓ 0.14 (-7.11%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$1.05B
P/E Ratio
-117.06
EPS
0.02
Dividend Yield
Not covered
52W Position
33%
Beta
1.65

Valuation multiples

Fwd P/E
12.94
PEG
Not covered
P/B
85.37
P/S
Not covered
EV/Revenue
Not covered
ROE
-72.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 33%
$0.83$3.85

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$8.99M
Total Assets
$13.81M
Free Cash Flow
-$11.13M

Recent news